The U.S. Food and Drug Administration (FDA) is expected to decide in the coming months whether or not to approve apitegromab, an experimental muscle-strengthening agent designed to improve motor function in people with spinal muscular atrophy (SMA). Scholar Rock, the company developing apitegromab, resubmitted its application about a month ago seeking the therapy’s approval for […] The post Apitegromab moves closer to potential FDA approval for kids, adults with SMA appeared first on SMA News Today .

Source: https://smanewstoday.com/news/sma-sets-september-30-decision-date-sma-therapy-apitegromab/ (Fri, 08 May 2026)

Ingested by the SMA platform's daily smanewstoday.com RSS pipeline. Cross-linked to our knowledge graph via the news auto-scoring cron.